» Articles » PMID: 31139713

Mapping and Profiling Lipid Distribution in a 3D Model of Breast Cancer Progression

Overview
Journal ACS Cent Sci
Specialty Chemistry
Date 2019 May 30
PMID 31139713
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Aberrant lipid accumulation and marked changes in cellular lipid profiles are related to breast cancer metabolism and disease progression. , these phenomena are primarily studied using cells cultured in monolayers (2D). Here, we employ multicellular spheroids, generated using the MCF10A cell line series of increasing malignancy potential, to better recapitulate the 3D microenvironmental conditions that cells experience . Breast cancer cell lipid compositions were assessed in 2D and 3D culture models as a function of malignancy using liquid chromatography coupled with mass spectrometry. Further, the spatial distribution of lipids was examined using Raman chemical imaging and lipid staining. We show that with changes in the cellular microenvironment when moving from 2D to 3D cell cultures, total lipid amounts decrease significantly, while the ratio of acylglycerols to membrane lipids increases. This ratio increase could be associated with the formation of large lipid droplets (>10 μm) that are spatially evident throughout the spheroids but absent in 2D cultures. Additionally, we found a significant difference in lipid profiles between the more and less malignant spheroids, including changes that support sphingolipid production and a reduction in ether-linked lipid fractions in the invasive spheroids. These differences in lipid profiles as a function of cell malignancy and microenvironment highlight the importance of coupled spatial and lipidomic studies to better understand the connections between lipid metabolism and cancer.

Citing Articles

TMEM106B deficiency leads to alterations in lipid metabolism and obesity in the TDP-43 knock-in mouse model.

Yang C, Lee G, Hao L, Hu F Commun Biol. 2025; 8(1):315.

PMID: 40011708 PMC: 11865606. DOI: 10.1038/s42003-025-07752-2.


Simultaneous visualization of membrane fluidity and morphology defines adhesion signatures of cancer cells.

Matsuzaki T, Fujii M, Noro H, Togo S, Watanabe M, Suganuma M Proc Natl Acad Sci U S A. 2024; 121(50):e2412914121.

PMID: 39636859 PMC: 11648891. DOI: 10.1073/pnas.2412914121.


Tunable Nanomaterials of Intracellular Crystallization for In Situ Biolabeling and Biomedical Imaging.

Liu H, Jiang H, Liu X, Wang X Chem Biomed Imaging. 2024; 1(9):767-784.

PMID: 39473839 PMC: 11504500. DOI: 10.1021/cbmi.3c00021.


Identification of Phospholipids Relevant to Cancer Tissue Using Differential Ion Mobility Spectrometry.

Sioris P, Makela M, Kontunen A, Karjalainen M, Vehkaoja A, Oksala N Int J Mol Sci. 2024; 25(20).

PMID: 39456784 PMC: 11508011. DOI: 10.3390/ijms252011002.


Bridging the gap: advancing cancer cell culture to reveal key metabolic targets.

Kes M, Berkers C, Drost J Front Oncol. 2024; 14:1480613.

PMID: 39355125 PMC: 11442172. DOI: 10.3389/fonc.2024.1480613.


References
1.
Miller F, Santner S, Tait L, Dawson P . MCF10DCIS.com xenograft model of human comedo ductal carcinoma in situ. J Natl Cancer Inst. 2000; 92(14):1185-6. DOI: 10.1093/jnci/92.14.1185a. View

2.
Santner S, Dawson P, Tait L, SOULE H, Eliason J, Mohamed A . Malignant MCF10CA1 cell lines derived from premalignant human breast epithelial MCF10AT cells. Breast Cancer Res Treat. 2001; 65(2):101-10. DOI: 10.1023/a:1006461422273. View

3.
Tauchi-Sato K, Ozeki S, Houjou T, Taguchi R, Fujimoto T . The surface of lipid droplets is a phospholipid monolayer with a unique Fatty Acid composition. J Biol Chem. 2002; 277(46):44507-12. DOI: 10.1074/jbc.M207712200. View

4.
Worgall T . Sphingolipids: major regulators of lipid metabolism. Curr Opin Clin Nutr Metab Care. 2007; 10(2):149-55. DOI: 10.1097/MCO.0b013e328028fda3. View

5.
Fischbach C, Chen R, Matsumoto T, Schmelzle T, Brugge J, Polverini P . Engineering tumors with 3D scaffolds. Nat Methods. 2007; 4(10):855-60. DOI: 10.1038/nmeth1085. View